Skip to main content

Tweets

EMR study identified 3.5+ million pts w/ BMI >30 -- 23% had sleep apnea (OSA). OSA had >2 fold risk of gout (7.2% vs 2.8%)vs those without OSA (p<0.0001). The odds of having gout are 2.65 times higher(HR 2.39; (CI) 2.367-2.419, p<0.0001). https://t.co/GgWrAiFPds https://t.co/QuQUk7nwDK
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
COVIDs Extended Risk for Rheumatic Disease Annals of Internal Medicine reports a large, binational study finding SARS-CoV-2 infection was associated with an increased risk for AIRDs that extends up to 12 months after infection. https://t.co/AIFc3B2YDP https://t.co/TzP49i6br8
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
85 pts w/ Myositis by MRI. Abnl MRI patterns correlated w/: - Honeycomb & foggy w TIF1γ or Mi2+, MSA-neg DM/PM, SRP+, HMGCR+ - Honeycomb w Cancer (OR 6.8), Gottrons(OR 8) - Foggy w weakness (OR 11.2) - Dense dot w dysphagia (OR 6.3) & CA https://t.co/kZGuNLFglg https://t.co/lK93U5iY7q
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Review of autoimmune Dz & adverse preg outcomes: Incr risk of: - Miscarriage w/ Sjögrens (RR 8.85) & SLE (OR 4.9) - Preeclampsia w/ SLE (OR 3.2) - IUGR w/ scleroderma (OR 3.2) & celiac (OR 1.71) - Preterm birth w/ SLE (OR 2.79). https://t.co/PdxJTK6mw3 https://t.co/ToQXgRoEsS
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
12 Best Hospitals in the USA according to Newsweek 1 Mayo Clinic 2 Cleveland Clinic 3 Johns Hopkins 4 MGH 5 UCLA Med Center 6 Stanford Hospital 7 Brigham & Womens 8 Mount Sinai NYC 9 Northwestern 10 University of Michigan 11 Cedars-Sinai 12 UCSF https://t.co/AJnJsWr4eY https://t.co/M2Abicf4eD
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Sandoz has announced FDA approval for their two interchangeable biosimilars of denosumab - Wyost (denosumab-bddz) and Jubbonti (denosumab-bddz) based on reference products Xgeva and Prolia https://t.co/5OmJHDYWmM https://t.co/iHsqlJ9wYl
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
DESIR study: new onset SpA pts followed w/ Xrays x 10 yrs showed progression from nr-axSpA to r-axSpA was 5.8% (in 294 followed 10 yrs), best predicted by baseline SI bone marrow edema, (OR 6.2), male, Sxs >1.5 yr, ASDAS ≥2.1 & smoking (only in HLA-B27+). https://t.co/A3Qqy8Eeym https://t.co/1I4UFI4h92
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Lancet - Full Read Review of the Diagnosis and management of ANCA-associated vasculitis by Stone, et al https://t.co/dtXOU8GT8p https://t.co/OXxdE8REGA
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Sniffles & Arthritis (3.1.2024) Dr. Cush reviews the news and journal reports from the past week on RheumNow. Are these associations with infection, biomarkers and weather real or imaginary? Linked or luck? Causal or casual? You decide.... https://t.co/xqoaycXeIm https://t.co/zQdXoj680T
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Head to Toe, There’s No Place These Cells Won’t Go Biana Modilevsky, DO presents her poster at RWCS 2024. https://t.co/AEd0gk6THj https://t.co/3Rsv07WwA9
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
Cross-sectional multicenter study of 500 ax-SpA pts on biologics found 25% w/ Irritable Bowel Syndrome (IBS) that was linked to being Female gender, unemployed, higher BASDAI & BASFI, multiple biologics, FM , anxiety, depression & lower physical activity. https://t.co/RSKVcXZwLt https://t.co/RGsw3fHr3H
Dr. John Cush @RheumNow ( View Tweet )
2 years 3 months ago
An assessment of screening for latent tuberculosis in patients initiating b/tsDMARD therapy found over 1 in 3 new b/tsDMARD users did not receive TB screening within recommended time window, as well as variation in screening between drug classes In AC&R https://t.co/MGsWNZCiPW https://t.co/QRFq1lqWt6
ACR_Journals @ACR_Journals ( View Tweet )
2 years 3 months ago
×